SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-178755
Filing Date
2022-06-22
Accepted
2022-06-22 16:00:33
Documents
12
Period of Report
2022-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d535327d8k.htm   iXBRL 8-K 22586
  Complete submission text file 0001193125-22-178755.txt   143681

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20220616.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20220616_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20220616_pre.xml EX-101.PRE 11268
6 EXTRACTED XBRL INSTANCE DOCUMENT d535327d8k_htm.xml XML 3382
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 221031993
SIC: 2834 Pharmaceutical Preparations